Articles from Biotech Financial Reports (November 1, 2004)

Title	Author	Type	Words
BODISEN BIOTECH SEES STRONG 3RD QTR FINANCIAL PERFORMANCE.		Brief Article	290
CANGENE REPORTS EARNINGS OF 52 CENTS PER SHARE FOR FISCAL 2004.			543
ENPATH REVISES GUIDANCE FOR 3RD QTR/REMAINDER 0F 2004.			819
ERESEARCHTECHNOLOGY UPDATES 3RD QTR/FULL YEAR OUTLOOK.			417
WORLDWIDE ANALGESIC MARKET TO REACH $75 BILLION BY 2010.			525